Literature DB >> 17195927

Multivariate survival analysis of histological parameters and clinical presentation in canine cutaneous mast cell tumours.

R Preziosi1, G Sarli, M Paltrinieri.   

Abstract

The Patnaik histological grade is a good method for the prediction of long-term mast cell tumour behaviour but it is influenced by subjective inter-observer variations and intratumoral heterogeneity. The present study evaluated each of the histopathological parameters used to formulate Patnaik's grade in terms of prognosis and tested whether they have a different prognostic sensitivity, thereby disclosing which could be considered more useful in the prediction of tumour recurrence and patient survival. Clinical presentation (single or multiple tumours) was also considered as possible prognostic factor. The results demonstrated that individual histological criteria together with multiple presentation may be of value in predicting the outcome of mast cell tumours. Among these, invasiveness (beta1.85; standard error 1.15) and the number of mitotic figures (beta3.01; standard error 1.18) showed high prognostic significance (Cox proportional hazard regression for censored data; chi-squared = 15.52, degree of freedom = 6, p = 0.016) and could serve as reliable prognostic indicators avoiding more subjective parameters such as cellular differentiation, nuclear morphology and tumoural pattern.

Entities:  

Mesh:

Year:  2006        PMID: 17195927     DOI: 10.1007/s11259-006-3427-9

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  16 in total

1.  Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.

Authors:  S Murphy; A H Sparkes; K C Smith; A S Blunden; M J Brearley
Journal:  Vet Rec       Date:  2004-06-12       Impact factor: 2.695

2.  Incomplete surgery, local immunostimulation, and recurrence of some tumour types in dogs and cats.

Authors:  W Misdorp
Journal:  Vet Q       Date:  1987-07       Impact factor: 3.320

3.  A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs.

Authors:  R al-Sarraf; G N Mauldin; A K Patnaik; K A Meleo
Journal:  J Vet Intern Med       Date:  1996 Nov-Dec       Impact factor: 3.333

4.  Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.

Authors:  Gina M Michels; Deborah W Knapp; Dennis B DeNicola; Nita Glickman; Patty Bonney
Journal:  J Am Anim Hosp Assoc       Date:  2002 Sep-Oct       Impact factor: 1.023

5.  Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.

Authors:  A K Patnaik; W J Ehler; E G MacEwen
Journal:  Vet Pathol       Date:  1984-09       Impact factor: 2.221

6.  Morphometry of canine cutaneous mast cell tumors.

Authors:  R De F Strefezzi; J G Xavier; J L Catão-Dias
Journal:  Vet Pathol       Date:  2003-05       Impact factor: 2.221

7.  Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.

Authors:  J J Abadie; M A Amardeilh; M E Delverdier
Journal:  J Am Vet Med Assoc       Date:  1999-12-01       Impact factor: 1.936

8.  Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog.

Authors:  R Preziosi; G Sarli; M Paltrinieri
Journal:  J Comp Pathol       Date:  2004 Feb-Apr       Impact factor: 1.311

9.  Prognosis of canine mast cell tumors: a comparison of three methods.

Authors:  J P Simoes; P Schoning; M Butine
Journal:  Vet Pathol       Date:  1994-11       Impact factor: 2.221

10.  Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours.

Authors:  D E Bostock; J Crocker; K Harris; P Smith
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

View more
  4 in total

1.  Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology.

Authors:  Ehsan Hosseini; Behnam Pedram; Ali Mohammad Bahrami; Seyed Rashid Touni; Hamed Zamankhan Malayeri; Aram Mokarizadeh; Mehdi Pourzaer; Maryam Pourzaer; Shahram Zehtabian; Sheida Mohajer; Sharareh Ahmadi
Journal:  Tumour Biol       Date:  2014-10-15

2.  The radiosensitizing effect of the aurora kinase inhibitors, ENMD-2076, on canine mast cell tumours in vitro.

Authors:  K Shiomitsu; E Sajo; C Rubin; I Sehgal
Journal:  Vet Comp Oncol       Date:  2013-06-13       Impact factor: 2.613

3.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

4.  Uterine mast cell tumor: a clinical and cytohistopathological study.

Authors:  Ali Mohammad Bahrami; Fariba Khaki; Shahram Zehtabian; Javad Cheraghi; Mehdi Rashnavadi; Mohammad Reza Hafezi Ahmadi; Mostafa Naderafif; Soheil Javaherypour; Siamak Mohsenzadeh; Ehsan Hosseini; Hamed Masoudi; Mehdi Pourzaer
Journal:  J Ovarian Res       Date:  2014-11-07       Impact factor: 4.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.